Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 9|pp. 7774–7798
The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Back to articleFigure 4(4 of 9)
100%
Figure 4
Figure 4.Survival curves (A–G) comparing the survival between different risk groups based on MPIGs across various datasets.